Related articles:

Sage Therapeutics Inc.: Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
February 23, 2017
February 23, 2017

Sage Therapeutics Inc.: Sage Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, February 23, 2017
February 17, 2017
February 17, 2017

Sage Therapeutics Inc.: Sage Therapeutics Not in M&A Discussions: STATEMENT
February 16, 2017
February 16, 2017

Sage Therapeutics Inc.: Sage Therapeutics to Participate in Upcoming February Investor Conferences
February 07, 2017
February 7, 2017

Sage Therapeutics Inc.: Sage Therapeutics to Webcast R&D Day on December 13, 2016
December 07, 2016
December 7, 2016

Sage Therapeutics Inc.: Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
August 09, 2016
August 9, 2016

Sage Therapeutics Inc.: Sage Therapeutics to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016
August 02, 2016
August 2, 2016

Sage Therapeutics Inc.: Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression
July 12, 2016
July 12, 2016

Sage Therapeutics Inc.: Sage Therapeutics Announces First Quarter 2016 Financial Results
May 05, 2016
May 5, 2016

Sage Therapeutics Inc.: Sage Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
April 28, 2016
April 28, 2016

Sage Therapeutics Inc.: Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
February 24, 2016
February 24, 2016

Sage Therapeutics Inc.: Sage Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results on Wednesday, February 24, 2016
February 17, 2016
February 17, 2016

Sage Therapeutics Inc.: SAGE Therapeutics Expands Leadership Team With Key Appointments
September 21, 2015
September 21, 2015

Sage Therapeutics Inc.: SAGE Therapeutics Announces Results From Successful Exploratory Trial in Essential Tremor
September 03, 2015
September 3, 2015

Sage Therapeutics Inc.: SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
August 12, 2015
August 12, 2015

Sage Therapeutics Inc.: SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results
May 14, 2015
May 14, 2015

Sage Therapeutics Inc.: SAGE Therapeutics to Report First Quarter 2015 Financial Results on Thursday, May 14
May 07, 2015
May 7, 2015

Sage Therapeutics Inc.: SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
February 27, 2015
February 27, 2015

Sage Therapeutics Inc.: SAGE Therapeutics Reports Third Quarter 2014 Results
November 11, 2014
November 11, 2014

Sage Therapeutics Inc.: SAGE Therapeutics Appoints Michael F. Cola to the Company's Board of Directors
September 16, 2014
September 16, 2014

Sage Therapeutics Inc.: SAGE Therapeutics Reports Second Quarter 2014 Financial Results
August 14, 2014
August 14, 2014

Sage Therapeutics Inc.: SAGE Therapeutics Announces Closing of Initial Public Offering
July 23, 2014
July 23, 2014

Sage Therapeutics Inc.: SAGE Therapeutics Announces Pricing of Initial Public Offering
July 17, 2014
July 17, 2014

Pin It on Pinterest

Share This